Australia markets closed

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
47.53+0.02 (+0.04%)
At close: 04:00PM EDT
47.55 +0.02 (+0.04%)
After hours: 07:47PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-528,628
-528,628
-652,172
-746,354
-344,874
Depreciation & amortisation
1,704
1,704
1,487
1,492
859
Stock-based compensation
105,945
105,945
91,085
70,667
45,376
Change in working capital
-200,169
-200,169
-15,698
-93,522
19,586
Accounts receivable
-198,715
-198,715
2,375
-10,103
0
Inventory
-60,647
-60,647
-69,397
-16,317
0
Accounts payable
170
170
18,689
10,487
-54
Other working capital
-595,508
-595,508
-515,269
-564,229
-165,910
Other non-cash items
26,293
26,293
28,663
6,327
15,536
Net cash provided by operating activities
-594,735
-594,735
-513,745
-563,126
-160,488
Cash flows from investing activities
Investments in property, plant and equipment
-773
-773
-1,524
-1,103
-5,422
Purchases of investments
0
0
-331,863
-171,281
-879,067
Sales/maturities of investments
0
0
393,280
420,000
567,500
Net cash used for investing activities
-674
-674
59,893
247,616
-316,989
Cash flows from financing activities
Debt repayment
-
-
-
0
0
Common stock issued
384,387
384,387
380,120
380,363
381,423
Other financing activities
-66,540
-66,540
-40,182
-5,788
-23,112
Net cash used provided by (used for) financing activities
394,499
394,499
365,659
392,236
692,178
Net change in cash
-200,775
-200,775
-88,681
74,710
215,060
Cash at beginning of period
553,074
553,074
641,755
567,045
351,985
Cash at end of period
352,299
352,299
553,074
641,755
567,045
Free cash flow
Operating cash flow
-594,735
-594,735
-513,745
-563,126
-160,488
Capital expenditure
-773
-773
-1,524
-1,103
-5,422
Free cash flow
-595,508
-595,508
-515,269
-564,229
-165,910